tiprankstipranks
Trending News
More News >
RedHill Biopharma Ltd (RDHL)
:RDHL
US Market

RedHill Biopharma (RDHL) Financial Statements

Compare
830 Followers

RedHill Biopharma Financial Overview

RedHill Biopharma's market cap is currently $2.64M. The company's EPS TTM is $; its P/E ratio is ―; RedHill Biopharma is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 8.04M$ 6.51M$ 61.80M$ 85.76M$ 64.36M
Gross Profit$ 4.85M$ 3.05M$ 28.46M$ 36.35M$ 27.47M
Operating Income$ -14.61M$ 12.63M$ -42.84M$ -81.14M$ -63.68M
EBITDA$ -7.59M$ 26.31M$ -42.84M$ -63.03M$ -54.94M
Net Income$ -8.27M$ 23.92M$ -59.24M$ -114.31M$ -89.02M
Balance Sheet
Cash & Short-Term Investments$ 4.62M$ 6.36M$ 19.98M$ 38.00M$ 29.79M
Total Assets$ 18.04M$ 23.05M$ 158.87M$ 181.19M$ 180.24M
Total Debt$ 356.00K$ 1.17M$ 122.69M$ 87.81M$ 86.90M
Net Debt$ -4.26M$ -4.40M$ 102.72M$ 58.34M$ 57.61M
Total Liabilities$ 22.73M$ 20.98M$ 207.27M$ 172.31M$ 166.38M
Stockholders' Equity$ -4.68M$ 2.07M$ -48.40M$ 8.88M$ 13.86M
Cash Flow
Free Cash Flow$ -9.38M$ -35.83M$ -29.38M$ -65.16M$ -102.35M
Operating Cash Flow$ -9.37M$ -35.82M$ -29.18M$ -65.05M$ -48.58M
Investing Cash Flow$ -9.00K$ 4.00K$ 8.30M$ -8.14M$ -35.65M
Financing Cash Flow$ 8.42M$ 21.44M$ 11.45M$ 73.46M$ 84.37M
Currency in USD

RedHill Biopharma Earnings and Revenue History

RedHill Biopharma Debt to Assets

RedHill Biopharma Cash Flow

RedHill Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis